PMC:7358770 / 32512-33684
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T317 | 402-409 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
| T318 | 419-423 | Body_part | denotes | cell | http://purl.org/sig/ont/fma/fma68646 |
| T319 | 424-428 | Body_part | denotes | cell | http://purl.org/sig/ont/fma/fma68646 |
| T320 | 476-488 | Body_part | denotes | glycoprotein | http://purl.org/sig/ont/fma/fma62925 |
| T321 | 652-656 | Body_part | denotes | cell | http://purl.org/sig/ont/fma/fma68646 |
| T322 | 739-746 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
| T323 | 960-973 | Body_part | denotes | glycopeptides | http://purl.org/sig/ont/fma/fma82784 |
| T324 | 1014-1029 | Body_part | denotes | polysaccharides | http://purl.org/sig/ont/fma/fma82746 |
| T325 | 1075-1089 | Body_part | denotes | polysaccharide | http://purl.org/sig/ont/fma/fma82746 |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 1119 | 492-502 | Species | denotes | SARS-COV-2 | Tax:2697049 |
| 1120 | 624-634 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
| 1121 | 750-760 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
| 1122 | 1158-1171 | Species | denotes | coronaviruses | Tax:11118 |
| 1123 | 305-316 | Chemical | denotes | hydrocarbon | MESH:D006838 |
| 1124 | 793-804 | Chemical | denotes | Carrageenan | MESH:D002351 |
| 1125 | 960-973 | Chemical | denotes | glycopeptides | MESH:D006020 |
| 1126 | 1014-1029 | Chemical | denotes | polysaccharides | MESH:D011134 |
| 1127 | 1035-1043 | Chemical | denotes | peptides | MESH:D010455 |
| 1128 | 1075-1089 | Chemical | denotes | polysaccharide | MESH:D011134 |
| 1129 | 378-391 | Disease | denotes | CoV infection | MESH:D018352 |
| 1130 | 588-613 | Disease | denotes | novel coronavirus disease | MESH:C000657245 |
| 1131 | 711-719 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T138 | 382-391 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
| T139 | 492-496 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T140 | 624-632 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T141 | 711-719 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T142 | 750-758 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T360 | 14-21 | http://purl.obolibrary.org/obo/PR_000018263 | denotes | peptide |
| T361 | 52-53 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T362 | 249-257 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activate |
| T363 | 303-304 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T364 | 341-348 | http://purl.obolibrary.org/obo/PR_000018263 | denotes | peptide |
| T365 | 419-423 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cell |
| T366 | 424-428 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cell |
| T367 | 437-440 | http://purl.obolibrary.org/obo/CLO_0001053 | denotes | 121 |
| T368 | 564-571 | http://purl.obolibrary.org/obo/PR_000018263 | denotes | peptide |
| T369 | 650-656 | http://purl.obolibrary.org/obo/CL_0000084 | denotes | T cell |
| T370 | 678-685 | http://purl.obolibrary.org/obo/PR_000018263 | denotes | peptide |
| T371 | 892-899 | http://purl.obolibrary.org/obo/PR_000018263 | denotes | peptide |
| T372 | 1035-1043 | http://purl.obolibrary.org/obo/PR_000018263 | denotes | peptides |
| T373 | 1053-1060 | http://purl.obolibrary.org/obo/PR_000018263 | denotes | peptide |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T487 | 14-21 | Chemical | denotes | peptide | http://purl.obolibrary.org/obo/CHEBI_16670 |
| T488 | 305-316 | Chemical | denotes | hydrocarbon | http://purl.obolibrary.org/obo/CHEBI_24632 |
| T489 | 341-348 | Chemical | denotes | peptide | http://purl.obolibrary.org/obo/CHEBI_16670 |
| T490 | 402-409 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
| T491 | 476-488 | Chemical | denotes | glycoprotein | http://purl.obolibrary.org/obo/CHEBI_17089 |
| T492 | 564-571 | Chemical | denotes | peptide | http://purl.obolibrary.org/obo/CHEBI_16670 |
| T493 | 678-685 | Chemical | denotes | peptide | http://purl.obolibrary.org/obo/CHEBI_16670 |
| T494 | 739-746 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
| T495 | 793-804 | Chemical | denotes | Carrageenan | http://purl.obolibrary.org/obo/CHEBI_3435 |
| T496 | 868-877 | Chemical | denotes | adjuvants | http://purl.obolibrary.org/obo/CHEBI_60809 |
| T497 | 892-899 | Chemical | denotes | peptide | http://purl.obolibrary.org/obo/CHEBI_16670 |
| T498 | 960-973 | Chemical | denotes | glycopeptides | http://purl.obolibrary.org/obo/CHEBI_24396 |
| T499 | 1014-1029 | Chemical | denotes | polysaccharides | http://purl.obolibrary.org/obo/CHEBI_18154 |
| T500 | 1035-1043 | Chemical | denotes | peptides | http://purl.obolibrary.org/obo/CHEBI_16670 |
| T501 | 1053-1060 | Chemical | denotes | peptide | http://purl.obolibrary.org/obo/CHEBI_16670 |
| T502 | 1075-1089 | Chemical | denotes | polysaccharide | http://purl.obolibrary.org/obo/CHEBI_18154 |
| T503 | 1090-1099 | Chemical | denotes | adjuvants | http://purl.obolibrary.org/obo/CHEBI_60809 |
| T504 | 1121-1132 | Chemical | denotes | application | http://purl.obolibrary.org/obo/CHEBI_33232 |
LitCovid-PD-GO-BP
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T75 | 262-278 | http://purl.obolibrary.org/obo/GO_0006955 | denotes | immune responses |
| T76 | 419-435 | http://purl.obolibrary.org/obo/GO_0140253 | denotes | cell-cell fusion |
| T77 | 419-435 | http://purl.obolibrary.org/obo/GO_0045026 | denotes | cell-cell fusion |
| T78 | 424-435 | http://purl.obolibrary.org/obo/GO_0000768 | denotes | cell fusion |
| T79 | 424-435 | http://purl.obolibrary.org/obo/GO_0000747 | denotes | cell fusion |
2_test
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| 32679328-11267969-48281340 | 133-136 | 11267969 | denotes | 117 |
| 32679328-20541583-48281341 | 137-140 | 20541583 | denotes | 118 |
| 32679328-20687873-48281342 | 280-283 | 20687873 | denotes | 119 |
| 32679328-17473845-48281343 | 284-287 | 17473845 | denotes | 120 |
| 32679328-29442512-48281344 | 437-440 | 29442512 | denotes | 121 |
| 32679328-32108359-48281345 | 636-639 | 32108359 | denotes | 122 |
| 32679328-20541583-48281346 | 950-953 | 20541583 | denotes | 118 |
| T74937 | 133-136 | 11267969 | denotes | 117 |
| T71655 | 137-140 | 20541583 | denotes | 118 |
| T75695 | 280-283 | 20687873 | denotes | 119 |
| T37103 | 284-287 | 17473845 | denotes | 120 |
| T51418 | 437-440 | 29442512 | denotes | 121 |
| T86458 | 636-639 | 32108359 | denotes | 122 |
| T82869 | 950-953 | 20541583 | denotes | 118 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T201 | 0-142 | Sentence | denotes | Additionally, peptide-based vaccines have become as a potentially important strategy for the development of therapeutic vaccination [117,118]. |
| T202 | 143-289 | Sentence | denotes | They do not require in vitro culture, making them biologically safe, and their selectivity can accurately activate the immune responses [119,120]. |
| T203 | 290-442 | Sentence | denotes | For example, a hydrocarbon-stapled short α-helical peptide can effectively inhibit MERS-CoV infection and its S protein-mediated cell-cell fusion [121]. |
| T204 | 443-645 | Sentence | denotes | The epitopes selected from the S glycoprotein of SARS-COV-2 can be used to design and prepare immunogenic multi-epitopic peptide vaccine against novel coronavirus disease caused by SARS-CoV-2 [122,123]. |
| T205 | 646-792 | Sentence | denotes | The T cell multi epitopes-based peptide vaccine was designed for COVID-19 using the envelope protein of SARS-CoV-2 as an immunogenic target [124]. |
| T206 | 793-955 | Sentence | denotes | Carrageenan and its structurally related compounds may serve as innovative adjuvants for enhancing peptide-based vaccine potency through immune enhancement [118]. |
| T207 | 956-1172 | Sentence | denotes | The glycopeptides prepared by the combination of selected polysaccharides with peptides, and the peptide vaccines with polysaccharide adjuvants, will have important application prospects for inhibiting coronaviruses. |
LitCovid-PMC-OGER-BB
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T933 | 262-268 | UBERON:0002405;GO:0006955 | denotes | immune |
| T934 | 269-278 | GO:0006955 | denotes | responses |
| T935 | 305-316 | CHEBI:24632;CHEBI:24632 | denotes | hydrocarbon |
| T936 | 331-340 | SO:0001117 | denotes | α-helical |
| T937 | 373-381 | SP_9 | denotes | MERS-CoV |
| T938 | 400-409 | PG_1 | denotes | S protein |
| T939 | 419-435 | GO:0000768 | denotes | cell-cell fusion |
| T940 | 447-455 | BV_9 | denotes | epitopes |
| T941 | 474-475 | PG_18 | denotes | S |
| T942 | 476-488 | PG_18;BV_11;CHEBI:17089;CHEBI:17089 | denotes | glycoprotein |
| T943 | 492-502 | SP_7 | denotes | SARS-COV-2 |
| T944 | 537-548 | CHEBI:60816;CHEBI:60816 | denotes | immunogenic |
| T945 | 594-605 | NCBITaxon:11118 | denotes | coronavirus |
| T946 | 624-634 | SP_7 | denotes | SARS-CoV-2 |
| T947 | 650-656 | CL:0000084 | denotes | T cell |
| T948 | 663-671 | BV_9 | denotes | epitopes |
| T949 | 711-719 | SP_7 | denotes | COVID-19 |
| T950 | 730-738 | GO:0031975 | denotes | envelope |
| T951 | 750-760 | SP_7 | denotes | SARS-CoV-2 |
| T952 | 767-778 | CHEBI:60816;CHEBI:60816 | denotes | immunogenic |
| T953 | 793-804 | CHEBI:3435;CHEBI:3435 | denotes | Carrageenan |
| T954 | 834-843 | CHEBI:36357;CHEBI:36357 | denotes | compounds |
| T955 | 868-877 | CHEBI:60809;CHEBI:60809 | denotes | adjuvants |
| T956 | 930-936 | UBERON:0002405 | denotes | immune |
| T957 | 960-973 | CHEBI:24396;CHEBI:24396 | denotes | glycopeptides |
| T958 | 1014-1029 | CHEBI:18154;CHEBI:18154 | denotes | polysaccharides |
| T959 | 1075-1089 | CHEBI:18154;CHEBI:18154 | denotes | polysaccharide |
| T960 | 1090-1099 | CHEBI:60809;CHEBI:60809 | denotes | adjuvants |
| T961 | 1158-1171 | NCBITaxon:11118 | denotes | coronaviruses |
| T29201 | 24-35 | CHEBI:24632;CHEBI:24632 | denotes | sed vaccine |
| T38172 | 50-59 | SO:0001117 | denotes | s a poten |
| T27608 | 92-100 | SP_9 | denotes | develop |
| T58136 | 119-128 | PG_1 | denotes | vaccinat |
| T77006 | 138-154 | GO:0000768 | denotes | 18]. They do not |
| T55132 | 166-173 | BV_9 | denotes | vitro c |
| T17354 | 192-193 | PG_18 | denotes | |
| T34950 | 194-206 | PG_18;BV_11;CHEBI:17089;CHEBI:17089 | denotes | iologically |
| T45518 | 210-220 | SP_7 | denotes | , and thei |
| T55501 | 255-266 | CHEBI:60816;CHEBI:60816 | denotes | te the immu |
| T26814 | 309-320 | NCBITaxon:11118 | denotes | ocarbon-sta |
| T7832 | 339-349 | SP_7 | denotes | l peptide |
| T48409 | 365-371 | CL:0000084 | denotes | inhibi |
| T39850 | 377-384 | BV_9 | denotes | -CoV in |
| T75873 | 424-432 | SP_7 | denotes | cell fus |
| T53766 | 443-452 | GO:0031975 | denotes | The epito |
| T48233 | 464-474 | SP_7 | denotes | from the |
| T88510 | 481-491 | CHEBI:60816;CHEBI:60816 | denotes | protein of |
| T42500 | 506-517 | CHEBI:3435;CHEBI:3435 | denotes | be used to |
| T33036 | 548-559 | CHEBI:36357;CHEBI:36357 | denotes | multi-epit |
| T93888 | 585-594 | CHEBI:60809;CHEBI:60809 | denotes | st novel |
| T37264 | 647-652 | UBERON:0002405 | denotes | he T |
| T61933 | 678-691 | CHEBI:24396;CHEBI:24396 | denotes | peptide vacci |
| T72359 | 732-747 | CHEBI:18154;CHEBI:18154 | denotes | velope protein |
| T61413 | 794-808 | CHEBI:18154;CHEBI:18154 | denotes | arrageenan and |
| T86563 | 809-818 | CHEBI:60809;CHEBI:60809 | denotes | its struc |
| T50142 | 877-890 | NCBITaxon:11118 | denotes | for enhancin |
| T76167 | 943-958 | CHEBI:18154;CHEBI:18154 | denotes | ement [118]. Th |
| T26865 | 999-1008 | CHEBI:75958;CHEBI:75958 | denotes | on of sel |
| T18990 | 1085-1092 | NCBITaxon:10239 | denotes | ride ad |
MyTest
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 1119 | 492-502 | Species | denotes | SARS-COV-2 | Tax:2697049 |
| 1120 | 624-634 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
| 1121 | 750-760 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
| 1122 | 1158-1171 | Species | denotes | coronaviruses | Tax:11118 |
| 1123 | 305-316 | Chemical | denotes | hydrocarbon | MESH:D006838 |
| 1124 | 793-804 | Chemical | denotes | Carrageenan | MESH:D002351 |
| 1125 | 960-973 | Chemical | denotes | glycopeptides | MESH:D006020 |
| 1126 | 1014-1029 | Chemical | denotes | polysaccharides | MESH:D011134 |
| 1127 | 1035-1043 | Chemical | denotes | peptides | MESH:D010455 |
| 1128 | 1075-1089 | Chemical | denotes | polysaccharide | MESH:D011134 |
| 1129 | 378-391 | Disease | denotes | CoV infection | MESH:D018352 |
| 1130 | 588-613 | Disease | denotes | novel coronavirus disease | MESH:C000657245 |
| 1131 | 711-719 | Disease | denotes | COVID-19 | MESH:C000657245 |